According to the procedure, the market for infertility treatment is divided into assisted reproductive technology (ART), artificial insemination (AI), fertilization and other procedures (including egg freezing, sperm freezing and fetal freezing). In 2016, the ART sector accounted for the largest portion of the infertility treatment market due to increased infertility and lifestyle disorders (decreased birth rate), technological innovation in IVF sector, increased adoption, surrogacy by same-sex couples, The same procedure is required. The ART market is further subdivided into IVF and surrogacy. The IVF segment accounts for the largest portion of the ART market. A large part of the IVF segment may be due to the high success rates associated with the procedure and the increased awareness and social acceptability of this method.
The infertility treatment market is fairly competitive, with a large number of global and local manufacturers of infertility treatment products. The Cooper Companies Inc. (U.S.), Cook Group Incorporated (U.S.), and Thermo Fisher Scientific, Inc. (U.S.) were the top three players in the infertility treatment market in 2016. Product launches, approvals, and product enhancements; agreements, partnerships, and collaborations; and geographic expansions were the major strategies adopted by most of the market players to achieve growth in the infertility treatment market